The Pediatric Leukemia and Lymphoma Steering Committee (PLLSC) addresses the design, prioritization, and evaluation of concepts for large clinical trials in pediatric hematologic cancers. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The PLLSC's membership comprises Children's Oncology Group (COG) representatives, community oncologists, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Chair
Stephen P. Hunger, M.D.
Children's Hospital of Philadelphia
Philadelphia, PA
Vice Chair
Tanja A. Gruber, M.D., Ph.D.
Stanford University
Palo Alto, CA
Members
Anjali S. Advani, M.D.
Cleveland Clinic
Cleveland, OH
Peter Aplan, M.D.
National Cancer Institute
Rockville, MD
Jameisha Brown, M.S.
Patient Advocate
Atlanta, GA
Michael J. Burke, M.D.
Children's Wisconsin
Milwaukee, WI
Jessica M. Foley, M.D.
Helen DeVos Children's Hospital
Grand Rapids, MI
Boris Freidlin, Ph.D.
National Cancer Institute
Bethesda, MD
Rebecca A. Gardner, M.D.
Seattle Children's Hospital
Seattle, WA
Robert J. Hayashi, M.D.
Washington University
St. Louis, MO
Eric Lowe, M.D.
Children's Hospital of the King's Daughter
Norfolk, VA
Selina M. Luger, M.D.
University of Pennsylvania
Philadelphia, PA
Megan Othus, Ph.D.
Fred Hutchinson Cancer Research Center
Seattle, WA
Pinki P. Prasad, M.D., M.P.H.
Louisiana State University Health Sciences Center
New Orleans, LA
Elizabeth A. Raetz, M.D.
New York University Grossman School of Medicine
New York, NY
Charles J. Schmaderer, M.B.A., CPA
Patient Advocate
Omaha, NE
Nita Seibel, M.D.
National Cancer Institute
Bethesda, MD
Lewis B. Silverman, M.D.
Columbia University Irving Medical Center
New York, NY
Malcolm Smith, M.D., Ph.D.
National Cancer Institute
Bethesda, MD
Matthew R. Sydes, M.Sc.
National Health Service
London, United Kingdom
Naomi Winick, M.D.
University of Texas Southwestern Medical Center
Dallas, TX
NCI CCCT Program Director
Elena Schwartz, Ph.D.
elena.schwartz@nih.gov